X @Bloomberg
Bloomberg·2026-03-04 19:17
MiniMed, a maker of diabetes management devices that will be separated from health giant Medtronic, is spurring debate among analysts over whether its growth prospects justify the valuation it’s seeking in an IPO https://t.co/ytdhuRTUjl ...